Why Usana Health Sciences Stock Plummeted This Week

Usana's Q2 earnings came in way below expectations, and sales were also lower than expected. Usana now expects to record a loss for the full-year period.

The Motley Fool • 19 hours ago

USANA Health Sciences Q2 Earnings Call Highlights

USANA Health Sciences NYSE: USNA said its core nutritional business remained in line with expectations during the second quarter of 2026, while near-term challenges at its Hiya and Rise Wellness ventures led the company to lower its full-year outlook.

MarketBeat • a day ago

USANA Health Sciences, Inc. (USNA) Q2 2026 Earnings Call Transcript

USANA Health Sciences, Inc. (USNA) Q2 2026 Earnings Call Transcript

Seeking Alpha • Aug 5, 2026

USANA Chairman, CEO Kevin Guest Shares 5 Ways to Make Happiness Happen at Work and Home This August

SALT LAKE CITY, Aug. 5, 2026 /PRNewswire/ -- With August recognized as Happiness Happens Month, Kevin Guest, Chairman and CEO of USANA Health Sciences (NYSE: USNA), is encouraging people to intentionally notice, create, and share more moments of genuine happiness at work and in their personal lives. "Happiness isn't a prize you receive after everything goes perfectly," said Guest, author of All the Right Reasons: 12 Timeless Principles for Living a Life in Harmony.

PRNewsWire • Aug 5, 2026

USANA Health Sciences: No Clear Growth Engine Left (Rating Downgrade)

USANA Health Sciences, Inc. stock fell sharply after Q2 earnings. The direct selling business has continued to shrink at quite a predictable pace. USNA's two growth brands, Hiya and Rise Wellness, showed a concerning performance. Revenues plummeted, and the brands' 2026 guidance was cut massively.

Seeking Alpha • Aug 5, 2026

USANA Health Sciences Reports Second Quarter 2026 Results

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal second quarter ended July 4, 2026. Key Financial Results Second Quarter 2026 vs. Second Quarter 2025 Net sales of $223 million versus $236 million. Net loss of $(21.4) million, which includes an estimated preliminary non-cash impairment charge(3) of $29.1 million, versus net earnings of $9.7 million. Diluted EPS of $(1.16) as compared with $0.52. Adjusted diluted EPS(1) of.

Business Wire • Aug 4, 2026

USANA Health Sciences (USNA) Reports Q2 Loss, Lags Revenue Estimates

USANA Health Sciences (USNA) came out with a quarterly loss of $0.07 per share versus the Zacks Consensus Estimate of $0.43. This compares to earnings of $0.74 per share a year ago.

Zacks Investment Research • Aug 5, 2026

New 12-Week Consumer Study Highlights Visible Skin Benefits with USANA Glow

Consumer study reports improvements in brighter-looking, more radiant, andmore even-toned skin after 12 weeks SALT LAKE CITY, July 30, 2026 /PRNewswire/ -- USANA Health Sciences (NYSE: USNA), a global leader in cellular nutrition, today announced the results of a new 12-week consumer study evaluating Glow, USANA's skincare supplement designed to support healthy, radiant-looking skin from within.* The 12-week consumer trial included 36 participants across the United States (22) and Mexico (14).

PRNewsWire • Jul 30, 2026

USANA Health Sciences Renews Four-Year Partnership with Nordiq Canada, Deepening Commitment to Clean Sport and Elite Athlete Nutrition

The renewed agreement extends USANA's role as the official nutrition partner of Nordiq Canada, supporting Canada's elite cross-country ski athletes through 2028 and beyond SALT LAKE CITY, July 20, 2026 /PRNewswire/ -- USANA Health Sciences, Inc. (NYSE: USNA), a global leader in science-based nutrition, today announced a renewal of its official partnership with Nordiq Canada, the national governing body for cross-country skiing in Canada. Under the renewed agreement, USANA will continue supplying Nordiq Canada's elite athletes with premium, NSF Certified for Sport® nutritional products designed to support performance, normal muscle recovery after exercise, and long-term health—through the 2030 Olympic Winter Games and beyond.

PRNewsWire • Jul 20, 2026

USANA Schedules Second Quarter 2026 Earnings Release and Conference Call

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that second quarter 2026 results will be released after the close of market on Tuesday, August 4, 2026. Shortly following the issuance of the Company's earnings release, the Company will post its Management Commentary document on the Company's Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and insti.

Business Wire • Jul 14, 2026